MINNEAPOLIS, Sept. 28 /PRNewswire/ -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced ...

Sacral neuromodulation is the most established technique for Overactive bladder, backed by long-term evidence of safety and efficacy. #medindia #neuromodulation’ Initial management of OAB generally ...

Uroplasty announced that ConnectiCare of the Emblem Health family of insurers began coverage of percutaneous tibial nerve stimulation, or PTNS, using its Urgent PC neuromodulation system for the ...

MINNEAPOLIS, Sept. 26, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding ...

SAN FRANCISCO—Patients with overactive bladder (OAB) who respond well to 12 weeks therapy with a percutaneous tibial nerve stimulation (PTNS) device are likely to have sustained improvement at 12 ...

This x-ray of the pelvis shows an electronic nerve-stimulating device in the right iliac fossa. The procedure is ideal in this population because it is minimally invasive and highly efficacious The ...

Overactive bladder (OAB) is defined as urinary urgency, with or without urge incontinence, often with frequency and nocturia. Initial therapy of OAB often includes anticholinergics and behavioral ...

Most patients with faecal incontinence are managed with conservative measures and biofeedback techniques Sacral nerve stimulation has dramatically changed the management of patients with faecal ...

EMKinetics, Inc. announced initiation of the TranStim Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder. The 120-person trial will ...

Uroplasty UPI, a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced significant new coverage decisions by ...